Multiomic Spatial Mapping of Myocardial Infarction and Implications for Personalized Therapy

Area of Science:

• Cardiovascular Biology
• Genomics
• Translational Medicine

Background:

• Ischemic heart disease, including myocardial infarction, remains a leading global cause of death.
• While early survival post-myocardial infarction has improved, long-term morbidity and mortality persist due to cardiac remodeling, heart failure, and electric instability.
• Current pharmacotherapies for heart failure lack targeted treatments for cardiac remodeling and fibrosis.

Purpose of the Study:

• To discuss recent advances in single-cell and spatial genomic technologies for understanding cardiac remodeling.
• To highlight the critical role of spatial information in identifying disease-driving cell populations and mechanisms.
• To explore the potential of these technologies in discovering novel therapeutic targets for heart failure.

Main Methods:

• Review of single-cell and spatial genomic technologies.
• Analysis of cellular and molecular heterogeneity in the heart.
• Integration of spatial information with genomic data.

Main Results:

• Single-cell and genomic technologies provide high-resolution mapping of the human heart.
• These methods reveal cellular and molecular heterogeneity but often lack spatial context.
• Spatial information is crucial for understanding tissue homeostasis and disease pathogenesis.

Conclusions:

• Spatial genomic technologies offer critical insights into cardiac remodeling and fibrosis mechanisms after injury.
• These advanced techniques can identify novel therapeutic targets for heart failure.
• The findings pave the way for developing new, targeted therapies to combat heart failure and improve long-term patient outcomes.